Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2007
11/22/2007US20070270433 Thiazolo-pyrimidine/pyridine urea derivatives
11/22/2007US20070270432 Novel Method
11/22/2007US20070270431 Preventive and/or Therapeutic Medicine for Rheumatoid Arthritis
11/22/2007US20070270430 Methods of Treating Cognitive Disorders Using Pyridyloxymethyl and Benzisoxazole Azabicyclic Derivatives
11/22/2007US20070270429 Function Inhibitor of Effector Cell
11/22/2007US20070270428 Use of Cyclooxygenase-2 Inhibitors for the Treatment of Depressive Disorders
11/22/2007US20070270427 vascular endothelial growth factor receptor inhibitors such as N2-(3-methyl-1H-indazol-6-yl)-N4-{3-[(methylsulfonyl)methyl]phenyl}-1,3,5-triazine-2,4-diamine trifluoroacetate, used as anticarcinogenic, antitumor or antiproliferative agents
11/22/2007US20070270426 Compounds for the treatment of neurodegenerative disorders
11/22/2007US20070270425 Substituted pyrimidinyl oxime kinase inhibitors
11/22/2007US20070270424 Heterocyclic inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1 and methods of using the same
11/22/2007US20070270423 Histamine 3 receptor antagonists/inverse agonists ; (4-isopropyl-piperazin-1-yl)-[1-(1-isopropyl-pyrrolidin-3-yl)-1H-indol-5-yl]-methanone; obesity, metabolic syndrome (syndrome X), and other eating disorders
11/22/2007US20070270422 Aromatic Compounds
11/22/2007US20070270421 Hepatocyte growth factor receptor inhibitors; Antitumor agents, anticarcinogenic agents, angiogenesis inhibitors; pyrimidine derivatives like Pyrrolidine-1-carboxylic acid [6-(2-fluoro-4-{3-[2-(4-fluorophenyl)acetyl]thioureido}phenoxy)pyrimidin-4-yl]amide
11/22/2007US20070270420 Heteroaryl compounds useful as inhibitors of gsk-3
11/22/2007US20070270419 Pyridinylpyrazolopyrimidinone derivatives as pde 7 inhibitors
11/22/2007US20070270418 Inhibitors of P38 and Methods of Using the Same
11/22/2007US20070270417 Antibacterial Agents
11/22/2007US20070270415 Benzothiadiazine compounds
11/22/2007US20070270414 Substituted benzoylguanidines, method for production and use thereof as medicament or diagnostic and medicament comprising the same
11/22/2007US20070270413 Mirtazapine for the treatment of neuropathic pain
11/22/2007US20070270412 Novel pharmaceuticals
11/22/2007US20070270411 Novel Diazepine Compounds as Ligands of the Melanocortin 1 and/or 4 Receptors
11/22/2007US20070270410 N3-[4-(4-Morpholin-4-yl-cyclohexyl)-phenyl]-1-pyridin-2-yl-1H-[1,2,4]triazole-3,5-diamine; antiproliferative agent; Alzheimer's Disease; Multiple Sclerosis Parkinson's Disease, asthma, schizophrenia, anti-nflammatory agent; cardiovascular disease; bone disorders
11/22/2007US20070270409 Medicament for Preventing and/or Treating Ischemic Cardiovascular Disease
11/22/2007US20070270408 Pharmaceutical use of substituted pyrazolo[1,5-a]pyrimidines
11/22/2007US20070270407 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
11/22/2007US20070270406 Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
11/22/2007US20070270405 Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
11/22/2007US20070270404 Tuberculosis treatment using pleuromutilin derivatives
11/22/2007US20070270403 Clozapine and Cocaine Effects on Dopamine and Serotonin Release in Nucleus Accumbens During Psychostimulant Behavior and Withdrawal
11/22/2007US20070270402 (+) or (-)-9-(piperazin-1-yl)-9,10-dihydropyrrolo[2,1-b][1,3]benzothiazepine; schizophrenia, paranoid states, manic-depressive states, social regression, personality regression, hallucination, appetite disorders
11/22/2007US20070270401 Thiazolyl-Dihydro-Indazole
11/22/2007US20070270400 New compounds 303
11/22/2007US20070270399 New compounds 302
11/22/2007US20070270398 New Compounds III
11/22/2007US20070270396 17-(Quaternary nitrogen(N-oxide)-alkylamino)-substituted; extracellular heat shock protein-90 inhibitors, anticarcinogenic agent; better bioavailability, less tixicity
11/22/2007US20070270395 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 2-Cyclopropylmethoxy-4-[4-(thiophene-2-carbonyl)-piperazin-1-yl]-quinoline-3-carbonitrile; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
11/22/2007US20070270394 Sex steroid precursor alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cGMP phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women
11/22/2007US20070270393 Methods and compositions for modulation of sleep cycle
11/22/2007US20070270392 Use of a Cyclopentenone Prostaglandin for Delaying the Onset and/or Preventing the Continuation of Labour
11/22/2007US20070270391 2Alpha-Methyl and 2Beta-Methyl Analogs of 19,26,27-Trinor-(20S)-1Alpha-Hydroxyvitamin D3 and Their Uses
11/22/2007US20070270390 Method of the treament of acne
11/22/2007US20070270389 Treating tetracycline resistant strains of Grampositive- or Gramnegative bacteria; antibiotics; [4S -(4a,5,5a,6,12a)]-4-(Dimethylamino)-9-[(-pyrrolidinocarbonyl)methyl]amino -1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide
11/22/2007US20070270388 Uses of 1-amino-3-(N,N-dimethylamino)-propylidene-1,1-bisphosphonic acid
11/22/2007US20070270387 e.g. (Z)-7-{(1R,2S,3R,5R)-3,5-Dichloro-2-[4-(1-hydroxy-hexyl)-phenyl]-cyclopentyl}-hept-5-enoic acid; prostaglandin EP2 selective agonists; glaucoma or ocular hypertension
11/22/2007US20070270386 Selective inhibitors of rock protein kinase and uses thereof
11/22/2007US20070270385 Substituted propane phosphinic acid esters
11/22/2007US20070270384 Process and intermediate
11/22/2007US20070270383 Phosphate derivatives of ritonavir or lopinavir; increased solubility; provide good oral absorption from formulations with higher drug load per unit dosage
11/22/2007US20070270382 Composition for Protecting Skin
11/22/2007US20070270381 Using phosphonium compound; therapy for oxidative stresses
11/22/2007US20070270380 Compositions useful for reducing nephrotoxicity and methods of use thereof
11/22/2007US20070270379 Inclusion Complexes Containing Piroxicam, a Cyclodextrin and Arginine
11/22/2007US20070270378 Viscous Agent for Ophthalmic Use
11/22/2007US20070270377 Oral Flora-Improving Agent, Antibacterial Agent and Growth Promoter
11/22/2007US20070270376 Combinations of Hyaluronic Acid and Polyunsaturated Fatty Acids
11/22/2007US20070270375 Obtained from plants of Barringtonia species which are derived from Barringtoside A and Barringtoside C as precursor compounds which especially have an arabinopyranosyl substituent at 21 position, which may optionally be further substituted with benzoyl, dibenzoyl, methyl butanoyl, at 3 or 4 position
11/22/2007US20070270374 2'-C-Methyl-Ribofuranosyl Cytidine Prodrugs, Pharmaceutical Compositions and Uses Thereof
11/22/2007US20070270373 N-Cyclopropyl 2-{3-[1-(4-nitrophenyloxycarbonyl)-4-piperidinyl]-1-propyn-1-yl}adenosine-5'-uronamide; myocardial perfusion, autoimmune diseases, inflammation, allergic diseases, skin diseases, infectious diseases, wasting diseases, organ transplantation
11/22/2007US20070270372 arresting heart of subject in need of heart surgery by exposing heart to effective amounts of a compound chosen from a potassium channel opener, a potassium channel agonist, an adenosine receptor agonist, and a local anaesthetic under conditions sufficient for heart to be arrested
11/22/2007US20070270371 Dosing and scheduling of oligomers
11/22/2007US20070270370 Novel bicyclonucleoside analogues
11/22/2007US20070270367 Rybozyme-catalyzed insertion of targeted sequences into RNA
11/22/2007US20070270364 Helicases
11/22/2007US20070270363 Modulation of telomere length by oligonucleotides having a G-core sequence
11/22/2007US20070270362 Methods and compositions for prevention or treatment of inflammatory-related diseases and disorders
11/22/2007US20070270361 Sars Nucleic Acids, Proteins, Vaccines, and Uses Thereof
11/22/2007US20070270360 Rna Interference Mediated Inhibition of Severe Acute Respiratory Syndrome (Sars) Gene Expression Using Short Interfering Nucleic Acid
11/22/2007US20070270359 Nucleic Acid-Based Compounds and Methods of Use Thereof
11/22/2007US20070270358 Cosmetic and/or Pharmaceutical Composition for the Treatment of the Rosacea
11/22/2007US20070270357 Bifunctional Macrolide Heterocyclic Compounds and Methods of Making and Using the Same
11/22/2007US20070270356 Substituted 9A-N-[N'-(Benzenesulfonyl)Carbamoyl-Y-Aminopropyl] and 9A-N-[N'(B-Cyanoethyl)-N'-(Benzenesulfonyl)Carbamoyl-Y-Aminopropyl]Derivatives of 9-Deoxo-9-Dihydro-9A-Aza-9A-Homoerithomycin A
11/22/2007US20070270355 Sport drink containing amino acids and carbohydrates
11/22/2007US20070270354 Azasugar derivatives, heparanase inhibitors, method for preparing same, compositions containing same, use thereof
11/22/2007US20070270353 Intrathecal administration of ziconotide, an Omega-conopeptide, and the anitoxidant methionine, and an analgesic selected from morphine, hydromorphone, fentanyl, sufentanil, and buprenorphine; ziconotide retains its potency and is physically and chemically compatible with the analgesic
11/22/2007US20070270352 Method of Treatment
11/22/2007US20070270351 Methods and Reagents for Regulation of Cellular Responses in Biological Systems
11/22/2007US20070270350 Methods and Compositions for the Prevention and Treatment of Inflammatory Diseases or Conditions
11/22/2007US20070270346 Compositions and methods comprising prostaglandin-related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia
11/22/2007US20070270345 Periocular drug delivery for diabetic retinopathy
11/22/2007US20070270342 Biotinylated hexadecasaccharides, preparation and use thereof
11/22/2007US20070270339 Use of GPCR54 Ligands for the Treatment of Infertility
11/22/2007US20070270338 prevention of cardiac cell death and prevention of cardiac tissue damage resulting from ischemic events in cardiac tissue; Cardiovascular disease such as angina, myocardial infarct (MI), and stroke
11/22/2007US20070270336 Method for accelerating cutaneous barrier recovery
11/22/2007US20070270335 Methods for alleviating deleterious effects of 3-deoxyglucosone
11/22/2007US20070270332 Methods and assays useful in the treatment of alcohol dependence or alcohol abuse
11/22/2007US20070270331 Modulators of gluconeogenesis
11/22/2007US20070270330 Preventing airway mucus production by administration of egf-r antagonists
11/22/2007US20070270307 Adsorbent And Process For Producing The Same
11/22/2007US20070269847 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer
11/22/2007US20070269541 Method and compositions for relieving menopausal and perimenopausal symptoms
11/22/2007US20070269540 Fat metabolism improving agent
11/22/2007US20070269539 Ginkgo Biloba Extract as a Treatment for Therapeutic-Induced Neurotoxicity
11/22/2007US20070269538 Method for accelerating secretion of estrogen and regenerating tissue cells of female sexual organs
11/22/2007US20070269537 Skin Condition Improvement Including Acne, Rosacea, and Topical Wounds by Artemisia Annua Extract via Iron Siderophore Trojan Horse Delivery System
11/22/2007US20070269536 Purified bilberry extract containing a mixture of glycosides of delphinidin, cyanidin, petunidin, peonidin, and malvidin; no added bisulfite ions; nutraceuticals and pharmaceuticals
11/22/2007US20070269534 Methods of treating skin to enhance therapeutic treatment thereof
11/22/2007US20070269533 Oral Dieting Composition Comprising Conjugated Linoleic Acid and Caffeine
11/22/2007US20070269531 Non-Steroid Anti-Inflammatory Agents with Vitamins, Minerals, and Dietary Supplements for the Prevention and Treatment of Primary, Secondary and Tertiary Cancer
11/22/2007US20070269530 Disinfectant and method of making
1 ... 3491 3492 3493 3494 3495 3496 3497 3498 3499 3500 3501 3502 3503 3504 3505 3506 3507 3508 3509 3510 3511 ... 7860